Global Deep Brain Stimulation
Global Deep Brain Stimulation

Deep Brain Stimulation Comprehensive Study by Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS), Application (Pain Management, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Depression, Dystonia, Parkinsonís disease, Others), Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator) Players and Region - Global Market Outlook to 2024

Deep Brain Stimulation Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Jul 2019 Edition 245 Pages 216 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
The study covers a detailed analysis segmented by key business segments i.e. by type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS and Pedunculopontine Nucleus DBS) , by application (Pain Management, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Depression, Dystonia, Parkinsonís disease and Others) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Deep Brain Stimulation market throughout the predicted period.

The competition is expected to become even more intense in the coming years with the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this Deep Brain Stimulation market analysis report suggests strategies Players can follow and recommends key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, including:
  • Boston Scientific Corp. (United States)
  • Medtronic plc (Ireland)
  • St. Jude Medical Inc. (United States)
  • Aleva Neurotherapeutics (Switzerland)
  • Beijing Pins Medical (China)
  • NeuroPace (United States)
  • NeuroSigma (United States)
  • Abbott Laboratories (United States)


In this players are continuously investing in technology advance devices and also focus on organic and inorganic growth strategies. The global Deep Brain Stimulation market is not much competitive. In terms of market share, few of the key players including Medtronic, Aleva presently dominate the global market. Key vendors with a prominent share in the global market are concentrating on escalating their client base the world.

Market Trend
Technological Innovations
Restraints
  • Progress/Risk of Technology
  • Substitutes Threat

Opportunities
DBS Science Helps To Define the Future Role of This Technology in the Growth of Novel Therapeutics for the Most Challenging Disorders Affecting the Human Brain

Key highlights of the Global Deep Brain Stimulation market Study:
• CAGR of the market during the forecast period 2018-2024
• Detailed information on factors that will accelerate the growth of the Deep Brain Stimulation market for the next five years.
• Forecast of the Global Deep Brain Stimulation market size and its contribution to the parent market by type, application and by country.
• Insights on upcoming trends and changes in consumer behaviour
• Uncovering market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of Deep Brain Stimulation Players

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Deep Brain Stimulation market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Deep Brain Stimulation market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Deep Brain Stimulation device Manufacturers, Suppliers, and Distributors, Government Regulatory and Research Organizations and End-Use Industries.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Subthalamic DBS
  • Globus Pallidus DBS
  • Thalamic DBS
  • Pedunculopontine Nucleus DBS
By Application
  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Obsessive-Compulsive Disorder (OCD)
  • Depression
  • Dystonia
  • Parkinsonís disease
  • Others
By Product
  • Single Channel Deep Brain Stimulator
  • Dual Channel Deep Brain Stimulator

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Needs of an Ageing Population Worldwide
      • 3.2.2. Increasing Depression and Alzheimer Disease
    • 3.3. Market Challenges
      • 3.3.1. Highly Focal Point Is Insufficient As a Means of Addressing Dysfunction of Multiple Circuits
    • 3.4. Market Trends
      • 3.4.1. Technological Innovations
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Deep Brain Stimulation, by Type, Application, Product and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Deep Brain Stimulation (Value)
      • 5.2.1. Global Deep Brain Stimulation by: Type (Value)
        • 5.2.1.1. Subthalamic DBS
        • 5.2.1.2. Globus Pallidus DBS
        • 5.2.1.3. Thalamic DBS
        • 5.2.1.4. Pedunculopontine Nucleus DBS
      • 5.2.2. Global Deep Brain Stimulation by: Application (Value)
        • 5.2.2.1. Pain Management
        • 5.2.2.2. Epilepsy
        • 5.2.2.3. Essential Tremor
        • 5.2.2.4. Obsessive-Compulsive Disorder (OCD)
        • 5.2.2.5. Depression
        • 5.2.2.6. Dystonia
        • 5.2.2.7. Parkinsonís disease
        • 5.2.2.8. Others
      • 5.2.3. Global Deep Brain Stimulation by: Product (Value)
        • 5.2.3.1. Single Channel Deep Brain Stimulator
        • 5.2.3.2. Dual Channel Deep Brain Stimulator
      • 5.2.4. Global Deep Brain Stimulation Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Deep Brain Stimulation: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boston Scientific Corp. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic plc (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. St. Jude Medical Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Aleva Neurotherapeutics (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Beijing Pins Medical (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. NeuroPace (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. NeuroSigma (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Abbott Laboratories (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Deep Brain Stimulation Sale, by Type, Application, Product and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Deep Brain Stimulation (Value)
      • 7.2.1. Global Deep Brain Stimulation by: Type (Value)
        • 7.2.1.1. Subthalamic DBS
        • 7.2.1.2. Globus Pallidus DBS
        • 7.2.1.3. Thalamic DBS
        • 7.2.1.4. Pedunculopontine Nucleus DBS
      • 7.2.2. Global Deep Brain Stimulation by: Application (Value)
        • 7.2.2.1. Pain Management
        • 7.2.2.2. Epilepsy
        • 7.2.2.3. Essential Tremor
        • 7.2.2.4. Obsessive-Compulsive Disorder (OCD)
        • 7.2.2.5. Depression
        • 7.2.2.6. Dystonia
        • 7.2.2.7. Parkinsonís disease
        • 7.2.2.8. Others
      • 7.2.3. Global Deep Brain Stimulation by: Product (Value)
        • 7.2.3.1. Single Channel Deep Brain Stimulator
        • 7.2.3.2. Dual Channel Deep Brain Stimulator
      • 7.2.4. Global Deep Brain Stimulation Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Deep Brain Stimulation: by Type(USD Million)
  • Table 2. Deep Brain Stimulation Subthalamic DBS , by Region USD Million (2013-2018)
  • Table 3. Deep Brain Stimulation Globus Pallidus DBS , by Region USD Million (2013-2018)
  • Table 4. Deep Brain Stimulation Thalamic DBS , by Region USD Million (2013-2018)
  • Table 5. Deep Brain Stimulation Pedunculopontine Nucleus DBS , by Region USD Million (2013-2018)
  • Table 6. Deep Brain Stimulation: by Application(USD Million)
  • Table 7. Deep Brain Stimulation Pain Management , by Region USD Million (2013-2018)
  • Table 8. Deep Brain Stimulation Epilepsy , by Region USD Million (2013-2018)
  • Table 9. Deep Brain Stimulation Essential Tremor , by Region USD Million (2013-2018)
  • Table 10. Deep Brain Stimulation Obsessive-Compulsive Disorder (OCD) , by Region USD Million (2013-2018)
  • Table 11. Deep Brain Stimulation Depression , by Region USD Million (2013-2018)
  • Table 12. Deep Brain Stimulation Dystonia , by Region USD Million (2013-2018)
  • Table 13. Deep Brain Stimulation Parkinsonís disease , by Region USD Million (2013-2018)
  • Table 14. Deep Brain Stimulation Others , by Region USD Million (2013-2018)
  • Table 15. Deep Brain Stimulation: by Product(USD Million)
  • Table 16. Deep Brain Stimulation Single Channel Deep Brain Stimulator , by Region USD Million (2013-2018)
  • Table 17. Deep Brain Stimulation Dual Channel Deep Brain Stimulator , by Region USD Million (2013-2018)
  • Table 18. South America Deep Brain Stimulation, by Country USD Million (2013-2018)
  • Table 19. South America Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 20. South America Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 21. South America Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 22. Brazil Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 23. Brazil Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 24. Brazil Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 25. Argentina Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 26. Argentina Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 27. Argentina Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 28. Rest of South America Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 29. Rest of South America Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 30. Rest of South America Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 31. Asia Pacific Deep Brain Stimulation, by Country USD Million (2013-2018)
  • Table 32. Asia Pacific Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 33. Asia Pacific Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 34. Asia Pacific Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 35. China Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 36. China Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 37. China Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 38. Japan Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 39. Japan Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 40. Japan Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 41. India Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 42. India Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 43. India Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 44. South Korea Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 45. South Korea Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 46. South Korea Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 47. Taiwan Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 48. Taiwan Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 49. Taiwan Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 50. Australia Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 51. Australia Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 52. Australia Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 53. Rest of Asia-Pacific Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 54. Rest of Asia-Pacific Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 55. Rest of Asia-Pacific Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 56. Europe Deep Brain Stimulation, by Country USD Million (2013-2018)
  • Table 57. Europe Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 58. Europe Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 59. Europe Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 60. Germany Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 61. Germany Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 62. Germany Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 63. France Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 64. France Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 65. France Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 66. Italy Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 67. Italy Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 68. Italy Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 69. United Kingdom Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 70. United Kingdom Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 71. United Kingdom Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 72. Netherlands Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 73. Netherlands Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 74. Netherlands Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 75. Rest of Europe Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 76. Rest of Europe Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 77. Rest of Europe Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 78. MEA Deep Brain Stimulation, by Country USD Million (2013-2018)
  • Table 79. MEA Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 80. MEA Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 81. MEA Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 82. Middle East Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 83. Middle East Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 84. Middle East Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 85. Africa Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 86. Africa Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 87. Africa Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 88. North America Deep Brain Stimulation, by Country USD Million (2013-2018)
  • Table 89. North America Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 90. North America Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 91. North America Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 92. United States Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 93. United States Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 94. United States Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 95. Canada Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 96. Canada Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 97. Canada Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 98. Mexico Deep Brain Stimulation, by Type USD Million (2013-2018)
  • Table 99. Mexico Deep Brain Stimulation, by Application USD Million (2013-2018)
  • Table 100. Mexico Deep Brain Stimulation, by Product USD Million (2013-2018)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Deep Brain Stimulation: by Type(USD Million)
  • Table 110. Deep Brain Stimulation Subthalamic DBS , by Region USD Million (2019-2024)
  • Table 111. Deep Brain Stimulation Globus Pallidus DBS , by Region USD Million (2019-2024)
  • Table 112. Deep Brain Stimulation Thalamic DBS , by Region USD Million (2019-2024)
  • Table 113. Deep Brain Stimulation Pedunculopontine Nucleus DBS , by Region USD Million (2019-2024)
  • Table 114. Deep Brain Stimulation: by Application(USD Million)
  • Table 115. Deep Brain Stimulation Pain Management , by Region USD Million (2019-2024)
  • Table 116. Deep Brain Stimulation Epilepsy , by Region USD Million (2019-2024)
  • Table 117. Deep Brain Stimulation Essential Tremor , by Region USD Million (2019-2024)
  • Table 118. Deep Brain Stimulation Obsessive-Compulsive Disorder (OCD) , by Region USD Million (2019-2024)
  • Table 119. Deep Brain Stimulation Depression , by Region USD Million (2019-2024)
  • Table 120. Deep Brain Stimulation Dystonia , by Region USD Million (2019-2024)
  • Table 121. Deep Brain Stimulation Parkinsonís disease , by Region USD Million (2019-2024)
  • Table 122. Deep Brain Stimulation Others , by Region USD Million (2019-2024)
  • Table 123. Deep Brain Stimulation: by Product(USD Million)
  • Table 124. Deep Brain Stimulation Single Channel Deep Brain Stimulator , by Region USD Million (2019-2024)
  • Table 125. Deep Brain Stimulation Dual Channel Deep Brain Stimulator , by Region USD Million (2019-2024)
  • Table 126. South America Deep Brain Stimulation, by Country USD Million (2019-2024)
  • Table 127. South America Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 128. South America Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 129. South America Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 130. Brazil Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 131. Brazil Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 132. Brazil Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 133. Argentina Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 134. Argentina Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 135. Argentina Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 136. Rest of South America Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 137. Rest of South America Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 138. Rest of South America Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 139. Asia Pacific Deep Brain Stimulation, by Country USD Million (2019-2024)
  • Table 140. Asia Pacific Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 141. Asia Pacific Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 142. Asia Pacific Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 143. China Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 144. China Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 145. China Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 146. Japan Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 147. Japan Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 148. Japan Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 149. India Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 150. India Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 151. India Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 152. South Korea Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 153. South Korea Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 154. South Korea Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 155. Taiwan Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 156. Taiwan Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 157. Taiwan Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 158. Australia Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 159. Australia Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 160. Australia Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 161. Rest of Asia-Pacific Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 162. Rest of Asia-Pacific Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 163. Rest of Asia-Pacific Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 164. Europe Deep Brain Stimulation, by Country USD Million (2019-2024)
  • Table 165. Europe Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 166. Europe Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 167. Europe Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 168. Germany Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 169. Germany Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 170. Germany Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 171. France Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 172. France Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 173. France Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 174. Italy Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 175. Italy Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 176. Italy Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 177. United Kingdom Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 178. United Kingdom Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 179. United Kingdom Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 180. Netherlands Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 181. Netherlands Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 182. Netherlands Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 183. Rest of Europe Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 184. Rest of Europe Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 185. Rest of Europe Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 186. MEA Deep Brain Stimulation, by Country USD Million (2019-2024)
  • Table 187. MEA Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 188. MEA Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 189. MEA Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 190. Middle East Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 191. Middle East Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 192. Middle East Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 193. Africa Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 194. Africa Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 195. Africa Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 196. North America Deep Brain Stimulation, by Country USD Million (2019-2024)
  • Table 197. North America Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 198. North America Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 199. North America Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 200. United States Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 201. United States Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 202. United States Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 203. Canada Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 204. Canada Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 205. Canada Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 206. Mexico Deep Brain Stimulation, by Type USD Million (2019-2024)
  • Table 207. Mexico Deep Brain Stimulation, by Application USD Million (2019-2024)
  • Table 208. Mexico Deep Brain Stimulation, by Product USD Million (2019-2024)
  • Table 209. Research Programs/Design for This Report
  • Table 210. Key Data Information from Secondary Sources
  • Table 211. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Deep Brain Stimulation: by Type USD Million (2013-2018)
  • Figure 5. Global Deep Brain Stimulation: by Application USD Million (2013-2018)
  • Figure 6. Global Deep Brain Stimulation: by Product USD Million (2013-2018)
  • Figure 7. South America Deep Brain Stimulation Share (%), by Country
  • Figure 8. Asia Pacific Deep Brain Stimulation Share (%), by Country
  • Figure 9. Europe Deep Brain Stimulation Share (%), by Country
  • Figure 10. MEA Deep Brain Stimulation Share (%), by Country
  • Figure 11. North America Deep Brain Stimulation Share (%), by Country
  • Figure 12. Global Deep Brain Stimulation share by Players 2018 (%)
  • Figure 13. Global Deep Brain Stimulation share by Players (Top 3) 2018(%)
  • Figure 14. Global Deep Brain Stimulation share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Boston Scientific Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Boston Scientific Corp. (United States) Revenue: by Geography 2018
  • Figure 18. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 19. Medtronic plc (Ireland) Revenue: by Geography 2018
  • Figure 20. St. Jude Medical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. St. Jude Medical Inc. (United States) Revenue: by Geography 2018
  • Figure 22. Aleva Neurotherapeutics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Aleva Neurotherapeutics (Switzerland) Revenue: by Geography 2018
  • Figure 24. Beijing Pins Medical (China) Revenue, Net Income and Gross profit
  • Figure 25. Beijing Pins Medical (China) Revenue: by Geography 2018
  • Figure 26. NeuroPace (United States) Revenue, Net Income and Gross profit
  • Figure 27. NeuroPace (United States) Revenue: by Geography 2018
  • Figure 28. NeuroSigma (United States) Revenue, Net Income and Gross profit
  • Figure 29. NeuroSigma (United States) Revenue: by Geography 2018
  • Figure 30. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 31. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 32. Global Deep Brain Stimulation: by Type USD Million (2019-2024)
  • Figure 33. Global Deep Brain Stimulation: by Application USD Million (2019-2024)
  • Figure 34. Global Deep Brain Stimulation: by Product USD Million (2019-2024)
  • Figure 35. South America Deep Brain Stimulation Share (%), by Country
  • Figure 36. Asia Pacific Deep Brain Stimulation Share (%), by Country
  • Figure 37. Europe Deep Brain Stimulation Share (%), by Country
  • Figure 38. MEA Deep Brain Stimulation Share (%), by Country
  • Figure 39. North America Deep Brain Stimulation Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Boston Scientific Corp. (United States)
  • Medtronic plc (Ireland)
  • St. Jude Medical Inc. (United States)
  • Aleva Neurotherapeutics (Switzerland)
  • Beijing Pins Medical (China)
  • NeuroPace (United States)
  • NeuroSigma (United States)
  • Abbott Laboratories (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation